GERM vs. XLVI
GERM (Amplify Treatments, Testing and Advancements ETF) and XLVI (State Street Health Care Select Sector SPDR Premium Income ETF) are both exchange-traded funds - GERM is a Health & Biotech Equities fund tracking the Prime Treatments, Testing and Advancements Index, while XLVI is a Derivative Income fund actively managed by State Street. GERM is passively managed, while XLVI is actively managed. GERM charges 0.68%/yr vs 0.35%/yr for XLVI.
Performance
GERM vs. XLVI - Performance Comparison
Loading charts...
Returns By Period
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
XLVI
- 1D
- 0.67%
- 1M
- 2.30%
- YTD
- -0.67%
- 6M
- 0.76%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
GERM vs. XLVI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | -0.67% | 12.79% |
GERM vs. XLVI - Sectors Allocation Comparison
Sectors
GERM
XLVI
Healthcare
-
Financial Services
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
GERM
XLVI
-
Financial Services
GERM
XLVI
Basic Materials
GERM
-
XLVI
-
Communication Services
GERM
-
XLVI
-
Consumer Cyclical
GERM
-
XLVI
-
Consumer Defensive
GERM
-
XLVI
-
Energy
GERM
-
XLVI
-
Industrials
GERM
-
XLVI
-
Real Estate
GERM
-
XLVI
-
Technology
GERM
-
XLVI
-
Utilities
GERM
-
XLVI
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GERM vs. XLVI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amplify Treatments, Testing and Advancements ETF (GERM) and State Street Health Care Select Sector SPDR Premium Income ETF (XLVI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| GERM | XLVI | Difference | |
|---|---|---|---|
Sharpe Ratio (All Time)Calculated using the full available price history | — | 1.33 | — |
Drawdowns
GERM vs. XLVI - Drawdown Comparison
The maximum GERM drawdown since its inception was 0.00%, smaller than the maximum XLVI drawdown of -8.14%. Use the drawdown chart below to compare losses from any high point for GERM and XLVI.
Loading charts...
Drawdown Indicators
| GERM | XLVI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -8.14% | +8.14% |
Max Drawdown (1Y)Largest decline over 1 year | 0.00% | — | — |
Current DrawdownCurrent decline from peak | 0.00% | -4.02% | +4.02% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -1.95% | +1.95% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.00% | — | — |
Volatility
GERM vs. XLVI - Volatility Comparison
Loading charts...
Volatility by Period
| GERM | XLVI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.00% | — | — |
Volatility (6M)Calculated over the trailing 6-month period | 0.00% | — | — |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 10.94% | -10.94% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 10.94% | -10.94% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 10.94% | -10.94% |
GERM vs. XLVI - Expense Ratio Comparison
GERM has a 0.68% expense ratio, which is higher than XLVI's 0.35% expense ratio.
Dividends
GERM vs. XLVI - Dividend Comparison
GERM has not paid dividends to shareholders, while XLVI's dividend yield for the trailing twelve months is around 11.53%.
| Position | TTM | 2025 |
|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% |
XLVI State Street Health Care Select Sector SPDR Premium Income ETF | 11.53% | 5.73% |
Frequently Asked Questions
On fees, XLVI is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
XLVI is cheaper with a 0.35% expense ratio, compared with 0.68% for GERM.
XLVI has the higher dividend yield at 11.53%, compared with 0.00% for GERM.
GERM is categorized as Health & Biotech Equities, while XLVI is Derivative Income. They also come from different issuers: Amplify and State Street. Their fees differ too: 0.68% for GERM and 0.35% for XLVI.
Find the right allocation for GERM and XLVI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer